Ovarian cancer in lymph nodes, Peritoneal cancer lymph nodes - Articole semnate de acelasi autor in Revista Practica Medicala:


Tema plagiatului este tot mai mult discutată în ultima vreme.

Overexpression of Bmi-1 has been reported in various human cancers and proved to be associated with poor survival. Disscusion: Bmi-1 is expressed by various tumors and therefore may contribute to malignant transformation.

Profilul de risc clinic asociat cancerului ovarian

Bmi-1 not only can lead mammary epithelial cells to senescence and immortalization, but also plays a key role in breast cancer. A significant correlation was observed between Bmi-1 expression and axillary lymph node metastases in lymph-ductal breast cancer.

ovarian cancer in lymph nodes suplimente de detoxifiere a conului

Bmi-1 is expressed in cervical cancer and correlated with a poorer prognosis, suggesting that this protein participates in the development and progress of cervical cancer. Regarding ovarian cancer, the results of several immunohistochemical studies revealed ovarian cancer in lymph nodes of Bmi-1, especially in poorly differentiated ovarian carcinoma. There is a strong correlation between histological grade, clinical stage and its expression.

Ovarian cancer lymph nodes

Conclusions: Human genes of polycomb group correlated with various hematological and epithelial cancers identify new mechanisms of ovarian cancer in lymph nodes transformation and pave the way for developing new cancer treatments and identify new diagnostic markers. Bmi-1 and its expression in tissues taken from patients with cervical, breast and ovarian cancer could be a marker for diagnosis and prognosis, and not least a potential target of antitumor therapy.

  • Peritoneal cancer early symptoms, Neuroendocrine cancer specialists Peritoneal cancer lymph nodes Translation of "peritoneale" in English Peritoneal cancer lymph nodes V-ar putea interesa Peritoneal cancer surgery.
  • Hpv ovarian cancer - topvacanta.ro

Sauvageau M, Sauvageau G. PLoS Biol,6 4 : e Posterior transformation, neurological, abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev ; 8: — Bmi-1 is essential for the tumorigenicity of neuroblastoma cells.

Ovarian cancer lymph nodes This study was performed to evaluate the clinical risk profile of patients with ovarian tumors who were surgically treated, measuring the survival rate at 5 years. Furthermore, the surgical treatment by TNM stages was achieved, measuring the survival rate after five years of follow-up. Most of the patients with malignant disease were multiparous Moreover, from menopausal patients, the higher prevalence was seen at the group between 45 and 55 years old, not being dependent on the earlier appearance.

Am J Pathol ; 5. Mihuțiu S.

EXPRESSION OF BMI-1 PROTEIN IN CERVICAL, BREAST AND OVARIAN CANCER

Corelații anatomo-clinice cu prognosticul în cancerul ovarian epitelial. Teza de doctorat, Facultatea de Medicina, Oradea Armstrong DK.

ovarian cancer in lymph nodes ce este condilomul și originea acestuia

Relapsed какой из форекс брокеров лучший cancer: challenges and management strategies for a chronic disease. Oncologist, ; 7 Suppl 5 : 20— Biochemical mechanisms of cisplatin cytotoxicity.

  • This study was performed to evaluate the clinical risk profile of patients with ovarian tumors who were surgically treated, measuring the survival rate at 5 years.
  • Profilul de risc clinic asociat cancerului ovarian

Anticancer Agents Med Chem ; 7: 3— Intensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinoma. BMC ; Global cancer statistics. J Clin. Relation of tumor size, lymph node status, and survival in 24, breast cancer cases.

Peritoneal cancer lymph nodes

Cancer ; 63 1 : — Bmi-1promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer. Mol Cancer ; 10 1 : Expression of BMI-1 and Mel in breast tissue-a diagnostic marker in patients with breast cancer.

BMC Cancer; Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients. Breast Cancer Res. The role of neoadjuvant chemotherapy and surgery in cervical cancer Int J Gynecol Cancer ; 20 11 Suppl 2 : S Neoadjuvant chemotherapy locally advanced cancer reduces surgical risks and lymph-vascular space involvement.

ovarian cancer in lymph nodes enterobius vermicularis lijecenje

Chin J Cancer. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.

Hpv ovarian cancer

Int J Gynecol Cancer. Overexpression of Bmi-1 in uterine cervical cancer: correlation with clinicopathology and prognosis.

LAPAROSCOPIC RETROPERITONEAL STAGING WITH PARA-AORTIC LYMPHADENECTOMY FOR OVARIAN CANCER

Overexpression of polycomb protein BMI-1 in human specimens of breast, ovarian, endometrial and cervical cancer. Anticancer Res.